Zafirlukast is contraindicated in persons having a historical past of hypersensitivity reactions towards the Energetic drug ingredient as well as the inactive compounds in the formulation, such as povidone, lactose, titanium dioxide, or cellulose. Zafirlukast is thoroughly hepatically metabolized by an enzyme referred to as CYP2C9. Zafirlukast inhibits the action https://harryg888epa1.wikievia.com/user